# Research Institute Hospital 12 de Octubre

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/research-institute-hospital-12-de-octubre/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 58.9 |
| Citations | 961,449 |
| City | Madrid |
| Country | ES |
| Description | Research Institute Hospital 12 de Octubre is a research organisation in Madrid, ES. OpenAlex records 15,605 works and 961,449 citations for it. 4,842 researchers list it as their most recent affiliation. |
| Homepage | https://imas12.es/en/ |
| OpenAlex ID | https://openalex.org/I4210086614 |
| Researchers | 4,842 |
| ROR ID | https://ror.org/002x1sg85 |
| Type | healthcare |
| Works | 15,605 |

## University papers

Showing 12 of 36.

- [Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort](https://scholariq.org/papers/neoadjuvant-chemotherapy-with-trastuzumab-followed-by-adjuvant-trastuzumab/)
- [Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study](https://scholariq.org/papers/pertuzumab-trastuzumab-and-docetaxel-for-her2-positive-metastatic-breast-cancer/)
- [The burden of chronic spontaneous urticaria is substantial: Real‐world evidence from <scp>ASSURE</scp>‐<scp>CSU</scp>](https://scholariq.org/papers/the-burden-of-chronic-spontaneous-urticaria-is-substantial-real-world-evidence/)
- [Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial](https://scholariq.org/papers/pembrolizumab-plus-pomalidomide-and-dexamethasone-for-patients-with-relapsed-or/)
- [The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy](https://scholariq.org/papers/the-starmen-trial-indicates-that-alternating-treatment-with-corticosteroids-and/)
- [Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative](https://scholariq.org/papers/genomic-and-transcriptomic-analyses-of-breast-cancer-primaries-and-matched/)
- [Duration of Treatment with Corticosteroids and Recovery of Kidney Function in Acute Interstitial Nephritis](https://scholariq.org/papers/duration-of-treatment-with-corticosteroids-and-recovery-of-kidney-function-in/)
- [Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification](https://scholariq.org/papers/mayo-clinic-consensus-report-on-membranous-nephropathy-proposal-for-a-novel/)
- [Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: Analyses from <scp>ASSURE</scp>‐<scp>CSU</scp>](https://scholariq.org/papers/angioedema-in-chronic-spontaneous-urticaria-is-underdiagnosed-and-has-a/)
- [EVA: Laparoscopic Instrument Tracking Based on Endoscopic Video Analysis for Psychomotor Skills Assessment](https://scholariq.org/papers/eva-laparoscopic-instrument-tracking-based-on-endoscopic-video-analysis-for/)
- [Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome](https://scholariq.org/papers/severe-and-malignant-hypertension-are-common-in-primary-atypical-hemolytic/)
- [Efficacy of omalizumab in chronic spontaneous urticaria refractory to conventional therapy: analysis of 110 patients in real-life practice](https://scholariq.org/papers/efficacy-of-omalizumab-in-chronic-spontaneous-urticaria-refractory-to/)

## University researchers

- [Fernando Caravaca‐Fontán](https://scholariq.org/researchers/fernando-caravaca-fontan/)
- [F.J. Ortiz de Frutos](https://scholariq.org/researchers/f-j-ortiz-de-frutos/)
- [Ignacio Oropesa García](https://scholariq.org/researchers/ignacio-oropesa-garcia/)

## University top topics

Showing 8 of 25.

- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Organ Transplantation Techniques and Outcomes](https://scholariq.org/topics/organ-transplantation-techniques-and-outcomes/)
- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Mitochondrial Function and Pathology](https://scholariq.org/topics/mitochondrial-function-and-pathology/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.